Prevalence and factors associated with human papilloma virus (HPV) infection among screening services recipients at Health promotion center 10th.
Keywords:
Human Papillomavirus Infection, Cervical Cancer, ScreeningAbstract
This study aims to investigate the prevalence and associated factors of HPV infection through a retrospective study using secondary data from the HPV DNA Test (HPVcxs2020) screening program by the National Cancer Institute, along with historical behavioral data collected via questionnaires. The sample comprised 1,178 women aged 25-59 years who met the selection criteria in Health Region 10. Data was collected from February to October 2023. Multiple logistic regression was utilized to determine associations, presented with Adjusted Odds Ratios (AOR) and 95% Confidence Intervals (CI) at a significance level of 0.05.
Results showed an HPV infection prevalence of 14.43%. Significant risk factors for HPV infection included being aged 26-35 years (AOR = 1.62; 95% CI: 1.02-2.57; P = 0.037) compared to older age groups, and not using condoms during sexual intercourse (AOR = 1.62; 95% CI: 1.14-2.15; P = 0.043) compared to using condoms. Hormonal contraceptive use was a protective factor (AOR = 0.62; 95% CI: 0.32-0.87; P = 0.037) compared to non-use of hormonal contraceptives.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021; 71(3): 209-49.
คณะแพทยศาสตร์ มหาวิทยาลัยเชียงใหม่ [อินเตอร์เน็ต]. มะเร็งปากมดลูก รู้เร็ว รักษาได้ [เข้าถึงเมื่อ 22 พฤศจิกายน 2566]. เข้าถึงได้จาก: https://www.med.cmu.ac.th/web/news-event/news/pr-news/9989/.
WHO [Internet]. Cervical cancer 2022 [cited 2023 17 November]. Available from: https://www.who.int/ news-room/fact-sheets/detail/cervical-cancer.
Boonyanurak P, Panichakul S, Wilawan K. Prevalence of high-risk human papillomavirus infection (HPV) and correlation with postmenopausal hormonal therapy in Thai women aged more than 45 years old. Medical journal of the Medical Association of Thailand. 2010; 93(1): 9.
Boonthum N, Suthutvoravut S. Prevalence, Types, and Associated Factors of HPV Infection Among Women with Abnormal Cervical Cytology Screening at Ramathibodi Hospital; 2021.
Bortolli APR, Treco IC, Vieira VK, Pascotto CR, Ferreto LED, Wendt GW, et al. Prevalence of HPV and associated factors in a population of women living in southern Brazil. Brazilian Journal of Microbiology. 2022; 53(4): 1979-86.
WHO [Internet]. New recommendations for screening and treatment to prevent cervical cancer 2021 [cited 2023 17 November]. Available from: https://www.who.int/news/item/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer.
สถาบันมะเร็งแห่งชาติ [อินเตอร์เน็ต]. โปรแกรมการคัดกรองมะเร็งปากมดลูกด้วยวิธี HPV DNA Test (HPVcxs2020) 2566 [เข้าถึงเมื่อ 16 พฤศจิกายน 2566]. เข้าถึงได้จาก:]. Available from: https://hpv.nci.go.th/login.jsp; jsessionid=721658065099B857E494DD8FEF22A479.
Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Statistics in medicine. 1998; 17(14): 1623-34.
Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression: John Wiley & Sons; 2013.
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The lancet global health. 2023; 11(2): 197-206.
กลุ่มงานดิจิทัลการแพทย์ สถาบันมะเร็งแห่งชาติ. ทะเบียนมะเร็งระดับโรงพยาบาล. สถาบันมะเร็งแห่งชาติ; 2564.
Faculty of Public Health Mahidol University [Interne]. Prevalence of HPV infection in Thai women 2022 2022 [cited 2024 16 June]. Available from: https://www.mahidol.ac.th/publications/2022
National Statistical Office of Thailand. National Health Survey 2023; 2023.
Termrungruanglert W, Khemapech N, Vasuratna A, Havanond P, Deebukkham P, Kulkarni AS, et al. The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand. Plos one. 2021;16(2): e0245894.
Vongpunsawad S, Rhee C, Nilyanimit P, Poudyal N, Jiamsiri S, Ahn HS, et al. Prevalence of HPV infection among Thai schoolgirls in the north-eastern provinces in 2018: implications for HPV immunization policy. IJID regions. 2023; 7: 110-5.
Phoolcharoen N, Kantathavorn N, Sricharunrat T, Saeloo S, Krongthong W. A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand. Gynecologic oncology reports. 2017; 21: 73-77.
Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006; 24: 4-15.
Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: a meta‐analysis update. International journal of cancer. 2007; 121(3): 621-632.
Liu Y, Zhang S, Song X, Wang X. Age-specific prevalence of HPV and its associated factors in women in Beijing, China. Epidemiology and Infection. 2016; 144((13): 2865-73.
Jiamsiri S, Rhee C, Ahn HS, Poudyal N, Seo H-W, Klinsupa W, et al. A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand. Plos one. 2022; 17(4): e0267294.
Gatechompol S, Teeratakulpisarn N, Wittawatmongkol O, Teeraananchai S, Kerr SJ, Chalermchockcharoenkit A, et al. Incidence, persistence, and factors associated with HPV infection among male adolescents with and without perinatally acquired HIV infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020; 85(5): 553-560.
Pierce Campbell CM, Lin H-Y, Fulp W, Papenfuss MR, Salmerón JJ, Quiterio MM, et al. Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. The Journal of infectious diseases. 2013; 208(3): 373-384.
Aneklap P, Chayachinda C, Klerdklinhom C, Thamkhantho M. Factors influencing inconsistent condom use in Thai HIV-infected heterosexual couples. Journal of the Medical Association of Thailand. 2020; 103(5): 504-511.
Gadducci A, Cosio S, Fruzzetti F. Estro-progestin contraceptives and risk of cervical cancer: a debated issue. Anticancer Research. 2020; 40(11): 5995-6002.
Akter T, Festin M, Dawson A. Hormonal contraceptive use and the risk of sexually transmitted infections: a systematic review and meta-analysis. Scientific Reports. 2022; 12(1): 20325.
